LOW-VOLUME · HOSP-MID
mebendazole Side Effects
mebendazole (also sold as Emverm) is a LOW-VOLUME FAERS extract #499 of 524 by FAERS report count. Still opens on HOSP-MID: 23.8% mention hospitalization (181 reports).
Data updated 2026-05-15
- 762
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
mebendazole: 23.8% mention hospitalization (181 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #499 of 524 by FAERS report count.
Thinner FAERS extract for mebendazole (Emverm) (762 reports #499 of 524 by FAERS report count). 23.8% mention hospitalization (181 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
FOETAL EXPOSURE DURING PREGNANCY leads 56 of 762 reports
Who reports · age peak 0-17 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 0-17 (182 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (54 reports, 7.1%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| FOETAL EXPOSURE DURING PREGNANCY | 15 |
| DEATH | 11 |
| EXOMPHALOS | 7 |
| DEHYDRATION | 6 |
| FOETAL MEGACYSTIS | 6 |
| SEPSIS NEONATAL | 5 |
| DISEASE PROGRESSION | 4 |
| PNEUMONIA | 4 |
| PYREXIA | 4 |
| ABDOMINAL TENDERNESS | 3 |
| AGRANULOCYTOSIS | 3 |
| ANAEMIA | 3 |
| ASTHENIA | 3 |
| DIARRHOEA | 3 |
| METABOLIC DISORDER | 3 |
| ABDOMINAL DISTENSION | 2 |
| ADVERSE EVENT | 2 |
| ATRIAL FIBRILLATION | 2 |
| BURNING SENSATION | 2 |
| CARDIAC FAILURE | 2 |
Reactions in Hospitalization Reports
Hospitalization mid-share (181, 23.8%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| NAUSEA | 23 |
| ABDOMINAL PAIN | 21 |
| VOMITING | 17 |
| PYREXIA | 15 |
| DIZZINESS | 12 |
| ASTHENIA | 11 |
| PAIN IN EXTREMITY | 10 |
| PRURITUS | 10 |
| DYSPNOEA | 9 |
| FATIGUE | 9 |
| MUSCULAR WEAKNESS | 9 |
| PNEUMONIA | 9 |
| ANXIETY | 8 |
| HEADACHE | 8 |
| HYPERTENSION | 8 |
| ABDOMINAL PAIN UPPER | 7 |
| CONVULSION | 7 |
| DECREASED APPETITE | 7 |
| ALANINE AMINOTRANSFERASE INCREASED | 6 |
How to read mebendazole FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-MID)
FAERS holds 762 voluntary reports linked to mebendazole (Emverm), 2004-2025. Death is listed on 54 (7.1%). Hospitalization appears on 181 (23.8%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with mebendazole
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 774 FAERS cases (Δ 12 heavier vs mebendazole); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 741 FAERS cases (Δ 21 lighter vs mebendazole); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 799 FAERS cases (Δ 37 heavier vs mebendazole); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 705 FAERS cases (Δ 57 lighter vs mebendazole); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 55.0 pp vs mebendazole's DEATH-HEAVY): CASELOAD · HOSP-MID.
mebendazole stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.